AUTOIMMUNITY Flashcards

1
Q

DAMAGE TO ORGANS OR
TISSUES RESULT FROM THE
PRESENCE OF THE
AUTOANTIBODY OR
AUTOREACTIVCE CELLS

A

AUTOIMMUNE DISEASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SELF TOLERANCE

A
  1. Clonal deletion of relevant effector cells.
  2. Activation regulation of T cell
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TOLERANCE MECHANISM

A
  1. Release of sequestered
    antigens
  2. Molecular mimicry
    3.Polyclonal B cell activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antigen that are protected from
encountering the circulation are not
exposed to potentially reactive
lymphocyte

A

sequestered
antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

EXAMPLE OF SEQUESTERED ANTIGEN

A

Myelin Basic proteins – sequestered by BBB
Sperm – Blood-testis barrie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Viral or bacterial agent contain antigens
that closely resemble self antigen.
Exposure can trigger antibody production
that in turn react with similar self-antige

A

MOLECULAR MIMICRY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

MOLECULAR MIMICRY EXAMPLE

A

Poliovirus VP2 – acetylcholine receptors
 Measles VP3 – Myelin Basic Protein (MBP)
Papilloma Virus E2 – insulin receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

B CELL DEFECTS

A

B cell defects:
1. Abnormal expression or function of Regulatory signaling
molecules.
2. Dysregulation of cytokines
3. Changes in B cell development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

the receptor for antibody that normally regulate
antibody production, may cause continual B cell stimulation.
Induce the proliferation of numerous clones of B cells
that express IgM in the absence of T helper cells. B cell can
be reactive to self antigen can be activated.

A

Defect: Fc receptor polymorphism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Other factors in autoimmunity

A

. Influence of hormones
2. Environmental condition
3. Defects in NK cells
4. Defects in the secretion of cytokines
5. Defects in apoptosis
6. Defects in complement componen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Systemic Lupus Erythematosus
(SLE)

A

Classic model of an autoimmune
disease
Systemic rheumatic disorder involving
multiple system
The immune response is directed
against the broad range of target
antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FORMS OF SLE

A
  1. Discoid (cutaneous)
     Limited to the skin and is identified by biopsy of the rash that may
    appear on the face, neck and scalp.
  2. Systemic
     More severe and can affect the skin, joints and almost all body system
     “lupus”
  3. Drug-induced
     Antiarrhythmic – procainamide hydrochloride
     Antihypertensive – Hydralazine hydrochloride
     Anticonvulsants- phenytoin
     Chlorpromazine, Isoniazid, Penicillin, sulfonamides
  4. Neonatal
     From passage of maternal autoantibodies, specifically anti-Ro/SS-A or
    anti-La/ SS-B that can affect the skin , heart and blood of the fetus and
    newborns
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ETIOLOGY OF SLE

A

Idiopatic
1. Hormonal influences
 Estrogen
 Antiphospholipid syndrome – complication of surgery
2. Genetic predisposition
3. Environmental factor
 UV lights may cause DNA to form thymine dimers that
can result to anti DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SIGNS AND SYMPTOMS OF SLE

A

Signs and Symptoms
 Achy joints (arthralgia)
 Frequent fevers >37C
 Arthritis (swollen joints)
 Prolonged extreme fatigue
 Skin rashes
 Anemia
 Kidney involvement
 Pain in the chest on deep breathing (pleurisy)
 Butterfly-shaped rash across the cheek and nose
 Photosensitivity
 Hair loss
 Abnormal clotting problems
 Raynaud’s phenomenon
 Seizure
 Mouth and nose ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DIAGNOSIS OF SLE

A

Diagnosis:
1. Malar rash
2. Discoid rash
3. Photosensitivity
4. Oral ulcers
5. Arthritis
6. Serositis
7. Renal disorders
8. Neurologic disorders
9. Hematologic disorders
10. Immunologic disorders
 Ab to dsDNA, SM Ag, phospholipids
11. Presence of ANA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neutrophil that has engulfed the antibody-coated
nucleus of another neutrophi

A

LE cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anti ds-DNA

A

 Most specific for SLE (diagnostic)
1. Indirect Immunofluorescence (IIF)
 Crithidia luciliae
2. Immunodiffusion
3. Radioimmunoassay (RIA)
4. Enzyme immunoassay (EIA) – sensitive
-most widely used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Anti-histone antibody

A

Histone is a nucleoprotein that is a major
constituent of chromatin
Drug induce Lupus- w/ ss-DNA
Also found in RA and biliary cirrhosis
 Immunofluorescence assay
 Immunoblotting
EIA
 IIF- homogenous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

DNA complexed to histone

A

Deoxynucleoprotein (DNP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Anti- Sm (Smith)

A

Specific for lupus, It cannot be found in
other autoimmune
Extractable nuclear antigens represent a
family of small nuclear proteins that are
associated with uridine rich RNA
Measured by immunodiffusion,
immunoblotting, immunoprecipitation and
EIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Anti SS-A/Ro and SS-B/Ro

A

Often found in cutaneous manifestations of
SLE, especially photosensitivity and
dermatitis.
Highly prevalent in scleroderma and
Sjogrens syndrome
Detected by immunoprecipitation ,
immunoblotting and EIA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Anti- nRNP antibody

A

Coarsely speckled IIF pattern.
Immunoblotting, immunoprecipitation , EIA
and IIF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Produces prolonged activated partial
thromboplastic time (aPT) and prothrombin time
(PTT)

A

Antiphospholipid antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Heterogenous group of antibodies that bind to
phospholipid alone or are complexed with protein.

Associated with deep-vein and arterial thrombosis
and with morbidity and pregnanc

A

Antiphospholipid antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
TREATMENT FOR SLE
Fever and arthritis- aspirin , antiinflammatory drug Skin manifestation – hydroxychloroquine or chloroquine, topical steroids Acute fulminant lupus, lupus nephritis ,CNS complications- systemic corticosteroids
26
Rheumatoid Arthritis
Strikes between 35 and 50 Characterized as chronic, symmetric and erosive arthritis of the peripheral joints that can also affect multiple organism such as the heart and lungs. Can affect organs such as heart and lungs. Associated with MHC class II which codes for beta chaiN
27
SIGNS OF RA
1. Morning stiffness around the joints lasting at least 1 hour 2. Swelling of the proximal interphalangeal, metacarpophalangeal, or wrist joints 3. Symmetric arthritis 4. Subcutaneous nodules 5. Rheumatoid factor (RF) positive 6. Radiographic evidence of erosions in the joints of the hands, wrist or both
28
NON SPECIFIC SYMPTOMS OF RA
Non specific symptoms  Malaise  Fatigue  Fever  Weight loss  Transient joint pain  Nodules over bones, myocardium, pericardium, heart valves, pleura, lungs, spleen and larynx  Systemic: anemia,subcutaneous nodules,pericarditris,lymphadenopathy,splenomegaly,interstiti al lungdisease,vasculitis
29
Chronic RA coupled with neutropenia, splenomegaly, and possibly thrombocytopeni
Felty’syndrome
30
INFECTIOUS AGENTS OF RA
 Mycoplasma  Rubella  Cytomegalovirus  EBV  parvovirus
31
IMMUNOLOGIC FINDINGS OF RA
 Pannus -  Continual inflammation  Proinflammatory – IL1, 6, 8 ,15, 18, TNF-α  Collagenase / tissue degrading enzymes – released from synoviocytes and chondrocytes that line joint cavity.
32
Increased cell lining of synovium and infiltration of mononuclear cells (CD4+ lymphocytes) -CD8+ T cells, B cells and plasma cells are scattered - (+) Macrophage and Neutrophils
PANNUS
33
– released from synoviocytes and chondrocytes that line joint cavity.
Collagenase / tissue degrading enzymes
34
AUTOANTIBODIES FOUND IN RA
 Rheumatoid Factor- IgM directed against the FC portion of IgG -Not specific  Antikeratin antibody  Antiperinuclear antibody  Antifilaggrin  Anti-Sa antibody  Antii- CCP (Cyclic citrullinated Peptide) - lead marker for detection of RA  Immune complex IgG-IgM deposited in joints resulting in type III hypersensitivity.  C1 bind to immune complex- activate classical complement cascade  C3a AND C5a act as chemotactic factor- chronic - inflammation - – damaged tissue
35
Antibodies are against Citrullinated proteins which are generated by modification of protein bound arginine by the enzyme peptidylarginine deiminase
RA
36
LAB DX OF RA
 Clinical manifestation  Radiographic findings  Laboratory testing  RF –  Agglutination:IgM only  Sheep RBC coated with IgG  Latex particles – predominant because it is more sensitivity  EIA - IgG, IgA, IgM  Nephelometry - IgG, IgA, IgM - scattering light of immune complex  Anti-CCP  EIA
37
TREATMENT FOR RA
 Anti-inflammatory (Ibuprofen and salicylates)  Control local swelling and pain  Disease Modifying Antirheumatic Drugs (DMARDS)  Methotrexate  Hydroxychloroquine  Sulfasalazine  Leflunomide  Penicillamine  Corticosteroid (prednizone) -halt inflammatory response  TNF-α blocker 1. Monoclonal antibody (infliximab, adalimumab) 2.. TNF-α receptor fused to an IgG molecule (etanercept) Rituximab – targets CD20 antigen on B cells
38
Autoimmune Thyroid Disease
1. Hashimoto’s Thyroiditis 2. Grave’s Disease
39
HASHIMOTO THYROIDITIS SIGNS AND SYMPTOMS
 AKA Chronic Autoimmune thyroiditis  S/S  Goiter  Hypothyroidism  Dry skin  Decreased sweating  Puffy face with edematous eyelids  Pallor with a yellow tinge  Weight gain  Dry brittle hair  Thyroid autoantibodies
40
GRAVE DISEASE S/S
 Hyperthyroidism`- most common cause  Thyrotoxicosis with goiter  Clinical symptoms  Nervousness  Insomnia  Depression  Weight loss  Heat intolerance  Sweating  Rapid heartbeat  Palpitations  Breathlessness  Symptoms  Exophthalmus
41
Graves disease - Antibody
1. Thyroid-stimulating hormone receptor Antibody (TSHRab) 2. Thyroid Peroxidase antibody 3. Thyrotropin receptor-blocking antibody
42
THYROID DISEASE LAB RESULTS
Presence of 1. Thyroglobulin antibodies - Hashimotos  IIF – less sensitive but detect non agglutinating antibodies - substrate: methanol fixed monkey cryostat tissue sections  Passive Hemagglutination – tanned red blood cells 2. Thyroid peroxidase antibodies-Hashimoto’s and Grave’s  Against enzyme that catalyzes tyrosine iodination  EIA  IIF  Particle agglutination 3. TSH receptor antibodies – Grave’s disease  Bioassay- require tissue  Binding assay –competition between radiolabeled TSH and patient autoimmune antibody 4. Colloid antibody (CA2) 5. TSH binding inhibitory immunoglobulin
43
EGENTIC AND ENVIRONMETNAL CAUSE OF DM
Genetic: associated with HLA-DR3 and DR4, DQ (DQβ)  Substitution for the amino acid 57 (Aspartic acid) of β chain  Environmental:  Viral infection  Rubella virus  Cytomegalovirus  Coxsackie B4 virus  Early exposure in Cow’s milk
44
may act as antigen presenting cells to activate T helper cells. Th1 then generates TNF-α, IFN-λ and IL-1. IN DM
B CELLS
45
Diabetes Mellitus - Autoantibodies
1. Anti-insulin antibodies 2. Antibodies to GAD enzyme 3. Islet cells antibodies ( ICAs)h 4. Antibodies to Insulinoma antigen 2 (IA-2or ICA 512) IA-2βA (Phogrin)
46
Diabetes Mellitus – Lab Dx
Islet cell Ab  IIF – frozen section of human pancreas RIA Anti-insulin , Anti-GAD RIA EIA
47
Diabetes Mellitus - Tx
 Insulin (IV)  Immunosuppressive agents  Cyclosporin A  Azathiorpine  Prednisone  Anti CD-20 (Rituximab) –under research
48
Multiple Sclerosis
Inflammatory, Autoimmune , CNS  Formation of Plaques in the white matter of the brain and spinal cord, leading to destruction of Myelin Sheathe of axons  Genetic: polymorphism in the gene coding for IL-7  Viral:EBV,measles, Herpes simplex, Varicella, Rubella, Influenza C, Human Herpes Virus-6, Para influenza virus
49
Multiple Sclerosis- S/s
 Visual disturbances  Diminished dexterity of limbs  Locomotors incoordination  Dizziness  Facial palsy  Tingling “pins and needles” of the spine or extremities  Flashes of light seen in eye movements
50
Pathogenesis OF MULTIPLE SCLEROSIS
Th1 (IL-1,TNF-α, INF-λ) Th2 (IL-4,IL-5, IL-10) Changes in endothelium to allow T cell To penetrate BBB Demyelination: predominant cells: T cells and macrophage .Attachment of antibody to myelin membrane Acute inflammation; injury to axons and glia, structural repair with recovery of some function ; post inflammatory neurodegeneration
51
LAB RESULT OF MULTIPLE SCLEROSIS
1. Oligoclonal Banding  Increased Ig in the CSF~ CSF protein electrophoresis  Presence of atleast 4 bands 1. CSFprotein electrophoresis 2. Isoelectric focusing with immunoblotting – more sensitive 2. CSF igG index  Compares the amount of IgG of spinal fluid to serum  Not specific
52
ANTIBODIES IN MULTIPLE SCLEROSIS
Antibodies against 1. Myelin basic protein peptides 2. Components of oligodendrocytes 3. Myelin membranes
53
 Autoimmune disease that affects the neuromuscular junction  Weakness and fatigability of skeletal muscle
Myasthenia Gravis
54
S/S OF MYASTHANIA GRAVIS
 Early signs:  Drooping of eyelids  Inability to retract the corners of the mouth “snarling”  Symptoms  Speaking  Chewing  Swallowing  Inability to support trunk, neck, head.
55
Associated with presence of SLE, RA, Pernicious Anemia, thyroiditis
Myasthenia Gravis
56
GENETIC DEFECT IN MYASTHENIA GRAVIS
 Early onset (<40 yo) – HLA antigen, A1, B8 and DR3  Late onset (>40yo) – HLA antigen B7  Men 30-60 – DR2  Thymic hyperplasia~ thymoma
57
Myasthenia Gravis - Lab Dx
1. RIA  Blocks the binding of the receptors by anti-ACH receptor (ACHR)  Use α-bungarotoxin snake venom to irreversibly bind to ACHR antibody  Precipitation is measured
58
Myasthenia Gravis - Tx
 Anticholinesterase agent  Thymectomy  Corticosteroids  Azathioprine  cyclosporine
59
Presence of autoantibody to glomerular basement membrane, renal tubular and alveolar basement membrane, resulting to renal failure and pulmonary hemorrhage Usually occurs after viral infection
Goodpasteur’s Syndrome Goodpasteur’s Syndrome
60
s/s of goodpasteur syndrom
 Signs: Renal involvement  Gross or microscopic hematuria  Proteinuria  Dec 24-hour creatinine clearance  Inc serum BUN and Creatinine  Signs: Pulmonary  Hemorrhage  Dyspnea  Weakness  Fatigue  Cough
61
Antibody against noncollagenous region of alpha 3 chain type IV collagen in glomerular and alveolar basement membranes
autoantibody
62
Specific anti-basement antibodies
 Formation of smooth, linear ribbonlike pattern on direct immunofluorescent assay of glomerular basement membrane
63
lab results for goodpasteur syndrome
1. RIA 2. EIA  Alpha 3 sub unit to detect Ab  Less sensitive that WB 3. IIF  Frozen kidney sections that are incubated with patient serum and then overlaid with fluorescein-labelled IgG  High false positive and negative 4. Western blot – confirmatory  Most sensitive and specific
64
treatment for goodpasteur syndrome
 Plasmapheresis  Dialysis  Immunosuppressive drugs  Glucocorticoids  Cyclophosphamide  Azathioprin
65